M0240 Casiri and imdev repeat

Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses

• Medicare coverage: Carrier judgment
• Status: terminated 20241212